Innovation to treat liver cancer in Eugene Marquis

Innovation to treat liver cancer in Eugene Marquis

[Source France 3 Régions]: In Rennes, the Eugène Marquis Centre, dedicated to the fight against cancer, is distinguished by unparalleled results in the treatment of certain liver cancers. This innovative technology, which consists of injecting radioactive microbeads, is however still reimbursed in France. At present, it is the Eugène Marquis Centre and the manufacturer who take charge of the extra cost. The Eugène Marquis Centre has been using this cutting-edge technology regularly for 6 years. 200 patients from all over France were treated. Their inoperable liver cancer usually leaves them with little life expectancy and few therapeutic options. This radioembolization treatment consists of injecting radioactive glass microbeads as close as possible to the tumor. For this, the radiologist introduces a catheter through the femoral artery of the patient to the liver. The second phase of the intervention is to send the microbeads. In principle, a single injection is sufficient for treatment. Thanks to this treatment, nearly one cancer in 4 becomes operable. The survival time of patients increases to 24 months compared to 8 months with conventional chemotherapy. These results are due in particular to a very personalized support. When his liver cancer was diagnosed 3 years ago, Marcel Goupil had only 6 months to live. Now in remission, he is a grateful patient. The cost of treatment is 20,000 euros and is not covered by the health insurance. Health authorities review the claim.

00

 

min

 

41

 

sec

File : Unicancer: the cancer centres

Publication date : 2 July 2013